Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
03/12/2008
Trade Name:
DAPTACEL
Generic or Proper Name (*):
Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed*
Indications Studied:
Active immunization as a booster dose against diphtheria, tetanus & pertussis
Therapeutic Category:
Preventive Vaccine
Ages Studied:
6 weeks - 6 years
Study #:
1
Study Type:
Safety/Immunogenicity
Study Design:
Open Label
No Patients:
649
No Centers:
22
No Countries:
1
BPCA(B), PREA(P):
P
-
-